Sigma Planning’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7K Buy
+10,115
New +$11.2K ﹤0.01% 1323

Other funds holding LCTX

Sigma Planning's LCTX Position: Q3 2026 in Review

Sigma Planning opened a new position in Lineage Cell Therapeutics (LCTX) in Q3 2026: 10,115 shares worth $9.7K. The stake represents ﹤0.01% of the portfolio and ranks #1323 among its holdings.

109 funds tracked by Wall St. Rank hold LCTX as of Q3 2026.

  • Sigma Planning held 10,115 shares of Lineage Cell Therapeutics worth $9.7K as of Q3 2026.
  • Lineage Cell Therapeutics was a new Sigma Planning position in Q3 2026.
  • Lineage Cell Therapeutics made up ﹤0.01% of Sigma Planning's portfolio in Q3 2026, its #1323 holding.
  • 109 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.